Patents by Inventor Mary Reyland

Mary Reyland has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tyrosine kinase inhibitors regenerate non-cancerous tissue after cancer therapy
    Patent number: 11376247
    Abstract: Methods for inducing the regeneration of non-cancerous tissues in a cancer patient undergoing radiotherapy and/or chemotherapy using continuous administration of tyrosine kinase inhibitors for at least 90 days following a cancer treatment in the patient.
    Type: Grant
    Filed: June 5, 2018
    Date of Patent: July 5, 2022
    Assignee: THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
    Inventors: Mary Reyland, Sten Wie
  • TYROSINE KINASE INHIBITORS REGENERATE NON-CANCEROUS TISSUE AFTER CANCER THERAPY
    Publication number: 20200138807
    Abstract: Methods for inducing the regeneration of non-cancerous tissues in a cancer patient undergoing radiotherapy and/or chemotherapy using continuous administration of tyrosine kinase inhibitors for at least 90 days following a cancer treatment in the patient.
    Type: Application
    Filed: June 5, 2018
    Publication date: May 7, 2020
    Inventors: Mary Reyland, Sten Wie